Replies to post #268550 on Avid Bioservices Inc (CDMO)

[EndoTarget]

Anyone knows if we are still producing for this.


Request for Proposals (RFP): NIAID Preclinical Development Support NIAID-DAIDS-NIHAI2015035

fbo.gov/index?s=opportunity&mode=form&id=0e284d4675e601e784380107cc5d443c&tab=core&_cview=1

I wish we bid since we were manufacturing...

This is an Indefinite Quantity contract as contemplated by FAR 16.504. The Contractor shall be reimbursed
by the Government in an amount not less than a total of $30,000 (minimum) nor more than a total of
$318,500,000 (maximum) for successful performance of this contract.

Process Development and CGMP Manufacture: Under this task area the Contractor shall produce vaccines and any other mucosally/systemically deliverable entities and research-grade products as requested by the Contracting Officer’s Representative (COR), including process development and production of CGMP products suitable for human clinical trials, and perform the necessary characterization tests required for release for clinical use. Transient transfection is one of the required methods for CGMP manufacture of HIV-1 proteins. This includes electroporation and other forms of transient transfection, and the CGMP expansion and harvest of cell substrates produced by such means for use in the manufacture of HIV-1 protein vaccines. Assume the initiation of 1 CGMP manufacturing project each year for 7 years.

[Carboat]

I believe King suggested Avid could be valued at 2-5 times gross sale

it is worth 2-5x sales if they get rid of all pphm staff and facilities. I don't see that happening.